Lim et al. transplanted PD-1-deficient and wild-type DCs into a mouse model of hepatocellular carcinoma (HCC) and showed that PD-1-deficient DCs can activate CD8+T cells more efficiently [17]. This evidence concerns the gene CD8A and hepatocellular carcinoma.